Trade now with Barclays Stockbrokers
| 18-Nov-25 |
Buy |
Jeremy Millard |
2.37p | 168,776 |
£3,999.99 |
| 18-Nov-25 |
Buy |
Carolyn Rand |
2.37p | 50,000 |
£1,182.50 |
| 18-Nov-25 |
Buy |
Carolyn Rand |
2.30p | 100,000 |
£2,300.00 |
| 05-Feb-25 |
Buy |
Carolyn Rand |
3.59p | 100 |
£3.59 |
| 29-Jan-25 |
Buy |
Carolyn Rand |
3.67p | 97,500 |
£3,576.30 |
| 18-Nov-25 |
Buy |
Jeremy Millard |
2.37p | 168,776 |
£3,999.99 |
| 29-Jan-25 |
Buy |
Carolyn Rand |
3.67p | 97,500 |
£3,576.30 |
| 18-Nov-25 |
Buy |
Carolyn Rand |
2.30p | 100,000 |
£2,300.00 |
| 18-Nov-25 |
Buy |
Carolyn Rand |
2.37p | 50,000 |
£1,182.50 |
| 05-Feb-25 |
Buy |
Carolyn Rand |
3.59p | 100 |
£3.59 |
| Jeremy Millard |
1,193,776 |
£22,383 |
| Carolyn Rand |
347,500 |
£6,516 |
| Spreadex Ltd |
22,432,673 |
£420,613 |
| Spreadex Ltd |
19,086,256 |
£357,867 |
| Spreadex Ltd |
17,761,256 |
£333,024 |
| Cantor Fitzgerald Europe |
14,516,000 |
£272,175 |
| Mobeus Equity Partners LLP |
8,333,250 |
£156,248 |
| Unicorn Asset Management |
4,266,650 |
£80,000 |
Top of Page
You are here:
research